ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,991.26
0.82%
Dow Jones
42,827.22
0.22%
US Dollar vs MXN
20.41996
-1.01%
Brent Oil
76.97
0.61%
Bitcoin
99,067.24
0.75%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Xenetic Biosciences Inc (XBIO)

  7. Xenetic Biosciences Inc (XBIO) Noticias

XBIO

Xenetic Biosciences (XBIO)

Xenetic Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:XBIO
FechaHoraFuenteTítuloSímboloCompañía
13/12/202416:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
13/12/202415:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XBIOXenetic Biosciences Inc
03/11/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:XBIOXenetic Biosciences Inc
31/10/202415:50Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:XBIOXenetic Biosciences Inc
31/10/202415:40Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:XBIOXenetic Biosciences Inc
31/10/202415:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:XBIOXenetic Biosciences Inc
21/10/202416:00Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:XBIOXenetic Biosciences Inc
13/08/202415:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XBIOXenetic Biosciences Inc
18/12/202316:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XBIOXenetic Biosciences Inc
18/09/202311:21Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:XBIOXenetic Biosciences Inc
15/06/202316:21Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:XBIOXenetic Biosciences Inc
02/06/202307:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XBIOXenetic Biosciences Inc
11/05/202315:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XBIOXenetic Biosciences Inc
22/03/202315:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:XBIOXenetic Biosciences Inc
09/12/202216:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XBIOXenetic Biosciences Inc
10/11/202208:35TipRanksH.C. Wainwright Keeps Their Buy Rating on Xenetic Biosciences (XBIO)NASDAQ:XBIOXenetic Biosciences Inc
21/10/202215:21Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:XBIOXenetic Biosciences Inc
17/10/202216:02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:XBIOXenetic Biosciences Inc
03/10/202216:13Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:XBIOXenetic Biosciences Inc
13/05/202205:36TipRanksXenetic Biosciences (XBIO) Gets a Buy Rating from H.C. WainwrightNASDAQ:XBIOXenetic Biosciences Inc
02/05/202205:17TipRanksH.C. Wainwright Maintains Their Buy Rating on Xenetic Biosciences (XBIO)NASDAQ:XBIOXenetic Biosciences Inc
28/04/202215:33Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:XBIOXenetic Biosciences Inc
28/04/202205:25TipRanksH.C. Wainwright Thinks Xenetic Biosciences’ Stock is Going to RecoverNASDAQ:XBIOXenetic Biosciences Inc
30/12/202115:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:XBIOXenetic Biosciences Inc
19/11/202115:55Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:XBIOXenetic Biosciences Inc
25/10/202105:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:XBIOXenetic Biosciences Inc
20/10/202115:31Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:XBIOXenetic Biosciences Inc
15/10/202116:00Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:XBIOXenetic Biosciences Inc
12/10/202116:25Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:XBIOXenetic Biosciences Inc
23/10/201915:25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XBIOXenetic Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:XBIO

Su Consulta Reciente

NASDAQ
GOOGL
Alphabet
NYSE
MCD
McDonalds
COIN
ETHUSD
Ethereum
NYSE
VZ
Verizon Communications
NYSE
JPM
JP Morgan Chase
NASDAQ
NVDA
NVIDIA
NYSE
CVX
Chevron
USOTC
BASFY
BASF (QX)
NYSE
NKE
Nike
AMEX
XLF
Financial Select Sector
NYSE
AXP
American Express
CCOM
SILVER
SILVER
USOTC
RHHBY
Roche (QX)
CCOM
US500
US 500
USI
USTECH100
US Tech 100
CCOM
OILBRENT
Brent Oil
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados